Evidence map›Paper›PMID 29875669›Full record

ArticleFrontiers in pharmacology2018

pH Responsive Polymer Micelles Enhances Inhibitory Efficacy on Metastasis of Murine Breast Cancer Cells.

Jie Wang, Gejing De, Qiaoxin Yue, Hai Ma, Jintang Cheng, Guangwei Zhu, Maobo Du, Hong Yi, Qinghe Zhao, Yanjun Chen

RetractedAbstract readRetracted Publication
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Jie WangInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Bejing, China.
Gejing DeInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Bejing, China.
Qiaoxin YueInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Bejing, China.
Hai MaInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Bejing, China.
Jintang ChengInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Bejing, China.
Guangwei ZhuInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Bejing, China.
Maobo DuInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Bejing, China.
Hong YiInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Bejing, China.
Qinghe ZhaoInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Bejing, China.
Yanjun ChenInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Bejing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A pH sensitive micellar cargo was fabricated for pH triggered delivery of hydrophobic drug paclitaxel with pH controlled drug release profiles. The size, drug loading content, and encapsulation efficiency of PTX loaded micelles were 20-30 nm, 7.5%, 82.5%, respectively. PTX loaded PELA-PBAE micelles could enhance the intracellular uptake of a model drug significantly, with increased cytotoxicity and inhibition of tumor metastasis on 4T1 cells, as confirmed by wound healing assay and tumor cells invasion assay. The expression of metastasis and apoptosis correlated proteins on 4T1 cells decreased remarkably after intervention by PTX loaded polymer micelles, as demonstrated by western blotting and quantitative reverse transcriptional-polymerase chain reaction (qRT-PCR). Our results demonstrated the pH responsive polymer micelles might have the potential to be used in the treatment of metastatic breast tumors.

Indexed as

4T1micellespaclitaxelpoly(β-amino ester)tumor metastasis

Identifiers

PMID29875669
PMCPMC5974204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.